Commerzbank Aktiengesellschaft’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-1,032
| Closed | -$232K | – | 370 |
|
|
2026
Q1 | $232K | Sell |
1,032
-57
| -5% | -$14.2K | ﹤0.01% | 337 |
|
|
2025
Q4 | $262K | Hold |
1,089
| – | – | 0.01% | 339 |
|
|
2025
Q3 | $299K | Hold |
1,089
| – | – | 0.01% | 311 |
|
|
2025
Q2 | $281K | Hold |
1,089
| – | – | 0.01% | 306 |
|
|
2025
Q1 | $244K | Hold |
1,089
| – | – | 0.01% | 308 |
|
|
2024
Q4 | $250K | Buy |
1,089
+165
| +18% | +$39.7K | 0.01% | 299 |
|
|
2024
Q3 | $226K | Buy |
+924
| New | +$206K | 0.01% | 280 |
|
|
2020
Q2 | – | Sell |
-4,920
| Closed | -$725K | – | 344 |
|
|
2020
Q1 | $725K | Buy |
4,920
+2,246
| +84% | +$358K | 0.03% | 218 |
|
|
2019
Q4 | $414K | Buy |
2,674
+286
| +12% | +$41.2K | ﹤0.01% | 567 |
|
|
2019
Q3 | $323K | Buy |
+2,388
| New | +$313K | ﹤0.01% | 710 |
|
|
2019
Q1 | – | Sell |
-2,587
| Closed | -$295K | – | 970 |
|
|
2018
Q4 | $295K | Buy |
2,587
+451
| +21% | +$48.3K | ﹤0.01% | 767 |
|
|
2018
Q3 | $246K | Sell |
2,136
-1,014
| -32% | -$111K | ﹤0.01% | 832 |
|
|
2018
Q2 | $326K | Buy |
3,150
+119
| +4% | +$12K | ﹤0.01% | 751 |
|
|
2018
Q1 | $298K | Buy |
3,031
+597
| +25% | +$56.4K | ﹤0.01% | 794 |
|
|
2017
Q4 | $206K | Buy |
+2,434
| New | +$201K | ﹤0.01% | 830 |
|
|
2017
Q2 | – | Sell |
-5,238
| Closed | -$377K | – | 863 |
|
|
2017
Q1 | $377K | Buy |
5,238
+14
| +0.3% | +$968 | 0.01% | 722 |
|
|
2016
Q4 | $324K | Sell |
5,224
-667
| -11% | -$40.9K | ﹤0.01% | 753 |
|
|
2016
Q3 | $382K | Sell |
5,891
-1,899
| -24% | -$126K | 0.01% | 647 |
|
|
2016
Q2 | $493K | Sell |
7,790
-168
| -2% | -$9.9K | ﹤0.01% | 680 |
|
|
2016
Q1 | $460K | Sell |
7,958
-619
| -7% | -$35K | ﹤0.01% | 721 |
|
|
2015
Q4 | $460K | Sell |
8,577
-151
| -2% | -$8.51K | ﹤0.01% | 897 |
|
|
2015
Q3 | $445K | Sell |
8,728
-1,894
| -18% | -$102K | ﹤0.01% | 817 |
|
|
2015
Q2 | $599K | Sell |
10,622
-61
| -0.6% | -$3.85K | ﹤0.01% | 941 |
|
|
2015
Q1 | $767K | Sell |
10,683
-1,742
| -14% | -$113K | ﹤0.01% | 856 |
|
|
2014
Q4 | $697K | Buy |
12,425
+344
| +3% | +$18K | ﹤0.01% | 931 |
|
|
2014
Q3 | $595K | Sell |
12,081
-8,981
| -43% | -$457K | ﹤0.01% | 941 |
|
|
2014
Q2 | $1.07M | Buy |
21,062
+2,129
| +11% | +$106K | 0.01% | 841 |
|
|
2014
Q1 | $846K | Sell |
18,933
-10,237
| -35% | -$460K | ﹤0.01% | 877 |
|
|
2013
Q4 | $1.27M | Buy |
29,170
+11,546
| +66% | +$584K | 0.01% | 834 |
|
|
2013
Q3 | $931K | Sell |
17,624
-1,987
| -10% | -$96.4K | ﹤0.01% | 875 |
|
|
2013
Q2 | $885K | Buy |
+19,611
| New | +$930K | ﹤0.01% | 944 |
|
Other funds holding RMD
Commerzbank Aktiengesellschaft's RMD Position: Q2 2026 in Review
Commerzbank Aktiengesellschaft sold out of ResMed (RMD) in Q2 2026, closing a stake of 1,032 shares — an estimated $232K sold.
Commerzbank Aktiengesellschaft first reported a position in RMD in Q2 2013 and held it in 31 quarters. The position peaked at $1.27M in Q4 2013. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- Commerzbank Aktiengesellschaft reported no remaining ResMed position as of Q2 2026 after selling out during the quarter.
- Commerzbank Aktiengesellschaft sold 1,032 ResMed shares in Q2 2026, an estimated $232K.
- Commerzbank Aktiengesellschaft first reported a position in ResMed in Q2 2013 and held it in 31 quarters.
- Commerzbank Aktiengesellschaft's ResMed position peaked at $1.27M in Q4 2013.
- 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on Commerzbank Aktiengesellschaft's 13F filing for Q2 2026, filed 7 Aug 2026.